Back to top
more

Amgen (AMGN)

(Delayed Data from NSDQ)

$272.45 USD

272.45
2,303,574

+2.81 (1.04%)

Updated Dec 1, 2023 04:00 PM ET

After-Market: $272.40 -0.05 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.96%
2Buy17.61%
3Hold8.96%
4Sell4.80%
5Strong Sell2.32%
S&P50010.64%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (47 out of 251)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for AMGN

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Amgen Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Assets          
Cash & Equivalents 9,305 8,037 10,647 8,911 29,304
Receivables 5,563 4,895 4,525 4,057 3,580
Notes Receivable 0 0 0 0 0
Inventories 4,930 4,086 3,893 3,584 2,940
Other Current Assets 2,388 2,367 2,079 1,888 1,794
Total Current Assets 22,186 19,385 21,144 18,440 37,618
Net Property & Equipment 5,427 5,184 4,889 4,928 4,958
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 31,609 30,072 31,276 34,116 22,142
Deposits & Other Assets 5,899 6,524 5,639 2,223 1,698
Total Assets 65,121 61,165 62,948 59,707 66,416
Liabilities & Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Notes Payable 0 0 0 0 0
Accounts Payable 1,572 1,366 1,421 1,371 1,207
Current Portion Long-Term Debt 1,591 87 91 2,953 4,419
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 12,524 10,731 10,141 8,511 7,862
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 15,687 12,184 11,653 12,835 13,488
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 606 864
Convertible Debt 0 0 0 0 0
Long-Term Debt 37,354 33,222 32,895 26,950 29,510
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 8,419 9,059 8,991 9,643 10,054
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 61,460 54,465 53,539 50,034 53,916
Shareholders Equity 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018
Preferred Stock 0 0 0 0 0
Common Stock (Par) 32,514 32,096 31,802 31,531 31,246
Capital Surplus 0 0 0 0 0
Retained Earnings -28,622 -24,600 -21,408 -21,330 -17,977
Other Equity -231 -796 -985 -528 -769
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 3,661 6,700 9,409 9,673 12,500
Total Liabilities & Shareholder's Equity 65,121 61,165 62,948 59,707 66,416
Total Common Equity 3,661 6,700 9,409 9,673 12,500
Shares Outstanding 533.50 558.30 582.10 594.10 637.20
Book Value Per Share 6.86 12.00 16.16 16.28 19.62

Fiscal Year End for Amgen Inc falls in the month of December.

All items in Millions except Per Share data.

9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Assets          
Cash & Equivalents 34,741 34,248 31,561 9,305 11,478
Receivables 6,145 5,830 5,736 5,563 5,326
Notes Receivable 0 0 0 0 0
Inventories 5,026 4,978 5,011 4,930 4,757
Other Current Assets 2,565 2,324 2,395 2,388 2,501
Total Current Assets 48,477 47,380 44,703 22,186 24,062
Net Property & Equipment 5,563 5,532 5,460 5,427 5,188
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 28,659 30,164 30,924 31,609 28,111
Deposits & Other Assets 7,835 7,193 7,633 5,899 6,339
Total Assets 90,534 90,269 88,720 65,121 63,700
Liabilities & Shareholders Equity 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Notes Payable 0 0 0 0 0
Accounts Payable 1,358 1,212 1,320 1,572 1,204
Current Portion Long-Term Debt 1,428 2,167 834 1,591 1,543
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 14,168 13,718 12,061 12,524 11,584
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 16,954 17,097 14,215 15,687 14,331
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 59,040 59,377 60,761 37,354 37,161
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 6,884 8,396 8,419 8,555
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 82,878 83,488 83,372 61,460 60,047
Shareholders Equity 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Preferred Stock 0 0 0 0 0
Common Stock (Par) 32,753 32,601 32,535 32,514 32,371
Capital Surplus 0 0 0 0 0
Retained Earnings -24,971 -25,540 -26,919 -28,622 -28,066
Other Equity -126 -280 -268 -231 -652
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 7,656 6,781 5,348 3,661 3,653
Total Liabilities & Shareholder's Equity 90,534 90,269 88,720 65,121 63,700
Total Common Equity 7,656 6,781 5,348 3,661 3,653
Shares Outstanding 535.10 534.30 534.30 533.50 534.90
Book Value Per Share 14.31 12.69 10.01 6.86 6.83